Alumis Inc.
ALMS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001847367
In the last 90 days, Alumis Inc. insiders filed 1 open-market purchase and 8 sales; 198 institutions reported holding it in 13F filings for Q2 2026, worth $3.32B in total; no superinvestor holds it.
13F holders, Q2 2024
Institutional positions in Alumis Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 29
- +29 vs. Q1 2024
- Shares held
- 28.6M
- +28.6M vs. Q1 2024
- Total value
- $380.0M
- +$380.0M vs. Q1 2024
- New holders
- 29
- 0 more added
- Sold out
- 0
- 0 more reduced
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ALMS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 198 | $3.32B |
| Q1 2026 | 197 | $2.53B |
| Q4 2025 | 134 | $771.1M |
| Q3 2025 | 130 | $312.3M |
| Q2 2025 | 112 | $235.0M |
| Q1 2025 | 72 | $246.8M |
| Q4 2024 | 64 | $316.5M |
| Q3 2024 | 52 | $376.4M |
| Q2 2024 | 29 | $380.0M |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Alumis Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| AyurMaya Capital Management Company, LP | 10,645,965 | $141.6M | 77.47% | +10,645,965 | New |
| Foresite Capital Management V, LLC | 5,584,887 | $74.3M | 47.43% | +5,584,887 | New |
| venBio Partners LLC | 2,826,048 | $37.6M | 16.23% | +2,826,048 | New |
| Cormorant Asset Management, LP | 2,147,400 | $28.6M | 1.66% | +2,147,400 | New |
| Sr One Capital Management, LP | 1,959,896 | $26.1M | 8.16% | +1,959,896 | New |
| Baker Bros. Advisors LP | 1,562,500 | $20.8M | 0.27% | +1,562,500 | New |
| Fan Yu | 789,618 | $10.5M | 13.72% | +789,618 | New |
| Omega Fund Management, LLC | 653,225 | $8.69M | 6.44% | +653,225 | New |
| Ally Bridge Group (NY) LLC | 618,750 | $8.23M | 4.90% | +618,750 | New |
| Morgan Stanley | 375,000 | $4.99M | 0.00% | +375,000 | New |
| Towerview LLC | 310,000 | $4.12M | 2.70% | +310,000 | New |
| Millennium Management LLC | 253,820 | $3.38M | 0.00% | +253,820 | New |
| Norges Bank | 250,000 | $3.33M | 0.00% | +250,000 | New |
| Sphera Funds Management Ltd. | 125,000 | $1.66M | 0.27% | +125,000 | New |
| Iron Triangle Partners LP | 125,000 | $1.66M | 0.17% | +125,000 | New |
| Vanguard Group Inc | 120,000 | $1.60M | 0.00% | +120,000 | New |
| Hudson Bay Capital Management LP | 37,500 | $498.8K | 0.00% | +37,500 | New |
| Maven Securities LTD | 25,000 | $332.5K | 0.05% | +25,000 | New |
| Polygon Management Ltd. | 24,350 | $323.9K | 0.10% | +24,350 | New |
| HRT Financial LP | 21,150 | $281.0K | 0.00% | +21,150 | New |
| Citadel Advisors LLC | 20,922 | $278.3K | 0.00% | +20,922 | New |
| Balyasny Asset Management LLC | 20,000 | $266.0K | 0.00% | +20,000 | New |
| Two Sigma Investments, LP | 19,000 | $252.7K | 0.00% | +19,000 | New |
| Landscape Capital Management, L.L.C. | 16,078 | $213.8K | 0.02% | +16,078 | New |
| Fifth Lane Capital, LP | 13,000 | $172.9K | 0.38% | +13,000 | New |
| Eisler Capital (US) LLC | 10,746 | $142.9K | 0.03% | +10,746 | New |
| Jane Street Group, LLC | 10,155 | $135.1K | 0.00% | +10,155 | New |
| Weiss Asset Management LP | 10,000 | $133.0K | 0.01% | +10,000 | New |
| Salem Investment Counselors Inc | 20 | $266 | 0.00% | +20 | New |